AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Invivyd, Inc. Director's Dealing 2021

Nov 3, 2021

33564_dirs_2021-11-03_d217fd17-642e-478c-8213-ea6f8af17e23.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2021-11-01

Reporting Person: Andersen Jill (Chief Legal Officer, Secretary)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2200	Direct
Common Stock	500	Indirect

Footnotes

F1: Shares owned by spouse.